The standard approach involves slowing dose escalation if side effects are severe, temporarily reducing the dose if a new tier causes significant discomfort, and providing dietary recommendations to minimize gastrointestinal symptoms
PRX2 has been found to be secreted by inflammatory cells and is elevated in synovial fluids and serum in patients with rheumatoid arthritis (Szabo-Taylor et al
Common Side Effects The most commonly reported adverse events are gastrointestinal in nature: Nausea (approximately 20-44% of participants) Diarrhea (approximately 30%) Vomiting (approximately 24%) These symptoms are typically mild to moderate in severity, tend to occur most frequently during dose escalation, and generally diminish over time as tolerance develops
From there, vagal fibers project to the nucleus of the solitary tract, and to the area postrema and dorsal motor nucleus [1]
DOAC medications (apixaban, rivarelbanan) are less affected by absorption timing changes
But like any therapy, how you use them is just as important as using them at all